Index of reports
> Life Threatening Events (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Elocon (Mometasone Furoate Topical) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Elocon side effects in female
Reported by a physician from Canada on 2012-07-27
Patient: female, weighing 97.5 kg (214.5 pounds)
Reactions: Liver Function Test Abnormal, Drug-Induced Liver Injury
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Betamethasone Valerate
Dosage: betaderm
Indication: Product Used FOR Unknown Indication
Tylenol W / Codeine NO. 3
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-03-28
End date: 2012-04-02
Misoprostol / Diclofenac
Dosage: arthrotec
Administration route: Oral
Indication: Musculoskeletal Pain
Start date: 2011-07-29
End date: 2012-05-07
Seroquel
Administration route: Oral
Indication: Depression
Elocon
Indication: Product Used FOR Unknown Indication
MS Contin
Dosage: 90 mg every morning and 120mg at bed time
Indication: Product Used FOR Unknown Indication
Lyrica
Administration route: Oral
Indication: Pain
Venlafaxine
Dosage: efexor xr
Administration route: Oral
Indication: Depression
Simvastatin
Administration route: Oral
Indication: Pain
Other drugs received by patient: Flonase
|